Replies to post #61169 on CV Sciences Inc (CVSI)

[MartyTamreau]

I'm not sure what you mean by "choked." You identified what looks like another legitimate competitor (along with Charlotte's Web). Choking implies that CVSI blew it, struck out with the game on the line. Not the case. Competition exists. Does Veritas have self-affirmed GRAS? A drug product 2 quarters away from a clinical trial application (CTA)? I didn't see the Veritas cash position, but we are cash positive and don't need to raise funds even to complete the Phase I study of nicotine-CBD gum.

It looks like Veritas is copying the model for growth as CVSI and in some of the same retailers. Competition is fine.

Dowling, Tomc and MacKay have not choked. They are laser-focused in a tough market with a handful of legitimate competitors. The other 1000-2000 brands will fall off once regulations are made clear.

MT

[jefra1965]

46% gross margin in tough times is dangerous. It's a young company. It still has a lot to proof. I understand the company has an MJ/hemp strain. I would wait for the regulations to get implemented. Cannabis type III is industrial hemp (Ditch weed). The gross margin didn't improve to acceptable levels despite the huge increase in sales, but small compare to bigger players. Over glut of hemp crops make other small companies a strong competition. The whole industry is upside down right now.

Too dangerous. Look what's happening to the bigger companies and the big MJ companies are changing their strategy amid stagnation.

How is the cash flow???

How did they achieve that growth in sales?? The gross margin tells the story.